0NQH (0NQH) Fair Value & Analysis

Healthcare · GB · Market cap €962M

0 0NQH 0NQH · LSE

Price€0.1270

Fair Value€0.0900

Upside-29.1%

Quality44/100

Watch 0NQH for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range €0.0900 – €0.0900

Fair value as of: Jun 26, 2026

From 25 valuation models · updated 9 days ago

Share price +14.6% over the past month.

Price vs Fair Value (12 months)

12‑month range €0.0857 – €0.1407 · the €0.1270 price screens above the €0.0900 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0NQH (0NQH) currently trades at €0.1270, while our model-based Fair Value estimate is €0.0900 — implying the stock looks roughly 29.1% overvalued today. We read business quality at 44/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

It earns a return on equity of 124.5%. Fundamentals as of Jun 26, 2026

For context, the median of 10 Healthcare peers we cover trades at -41% fair-value upside — at -29%, 0NQH screens cheaper than that median.

Key figures & financial health

Return on equity 125%

P/E ratio 457.3

EPS (TTM) €0.2186

Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2016 – FY2020 · reported fiscal years

0NQH reported revenue of €1.4B in FY2020 versus €1.2B in FY2016, a compound +3.7%/yr. Reported net income was €1.5M in FY2020, compounding −60.0%/yr from FY2016.

Revenue +3.7%/yr

FY16 €1.2B

FY17 €1.2B

FY18 €1.2B

FY19 €1.3B

FY20 €1.4B

Net income −60.0%/yr

FY16 €56.4M

FY17 €35.2M

FY18 €49.0M

FY19 €43.3M

FY20 €1.5M

Is 0NQH fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

0NQH · Fair Value
€0.0900 −29%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/0NQH" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">0NQH · Fair Value</span><br><b style="font-size:20px">€0.0900</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−29%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "0NQH Fair Value". https://www.fairvalue-calculator.com/stock/0NQH

Similar stocks

10 more Healthcare Providers & Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock	Price	Fair Value	vs Fair Value
Johnson & Johnson, JNJ	4,128 MXN	2,401 MXN	-42%
UnitedHealth Group UNH	7,169 MXN	5,226 MXN	-27%
Roche Holding ROGN	7,050 MXN	5,381 MXN	-24%
Merck & Co MRCK34	R$77.92	R$40.37	-48%
AstraZeneca PLC A1ZN34	R$159.89	R$87.02	-46%
Novartis AG N1VS34	R$76.88	R$56.26	-27%
Amgen Inc AMGN	6,170 MXN	3,666 MXN	-41%
Novo Nordisk A/S, NVON	733.11 MXN	230.36 MXN	-69%
Thermo Fisher Scientific Inc TMO	8,423 MXN	3,691 MXN	-56%
Gilead Sciences, Inc GILD	2,263 MXN	1,447 MXN	-36%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0NQH (0NQH) undervalued?

As of Jun 26, 2026, our model estimates a fair value of €0.0900 versus a price of €0.1270 — about −29% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0NQH?

Our model-based fair value for 0NQH is €0.0900 (as of Jun 26, 2026), built from audited fundamentals. The current price is €0.1270.

What is the quality score of 0NQH?

0NQH has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the net profit margin of 0NQH?

The net profit margin of 0NQH is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.